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Abstract
Background: One of the most important drawbacks in visceral leishmaniasis (VL) population studies is the difficulty of
diagnosing asymptomatic carriers. The aim of this study, conducted in an urban area in the Southeast of Brazil, was to
evaluate the performance of serology to identify asymptomatic VL infection in participants selected from a cohort with a
two-year follow-up period.
Methodology: Blood samples were collected in 2001 from 136 cohort participants (97 positive and 39 negatives, PCR/
hybridization carried out in 1999). They were clinically evaluated and none had progressed to disease from their
asymptomatic state. As controls, blood samples from 22 control individuals and 8 patients with kala-azar were collected.
Two molecular biology techniques (reference tests) were performed: PCR with Leishmania-generic primer followed by
hybridization using L. infantum probe, and PCR with specific primer to L. donovani complex. Plasma samples were tested by
ELISA using three different antigens: L. infantum and L. amazonensis crude antigens, and rK39 recombinant protein.
Accuracy of the serological tests was evaluated using sensitivity, specificity, likelihood ratio and ROC curve.
Findings: The presence of Leishmania was confirmed, by molecular techniques, in all kala-azar patients and in 117 (86%) of
the 136 cohort participants. Kala-azar patients showed high reactivity in ELISAs, whereas asymptomatic individuals
presented low reactivity against the antigens tested. When compared to molecular techniques, the L. amazonensis and L.
infantum antigens showed higher sensitivity (49.6% and 41.0%, respectively) than rK39 (26.5%); however, the specificity of
rK39 was higher (73.7%) than L. amazonensis (52.6%) and L. infantum antigens (36.8%). Moreover, there was low agreement
among the different antigens used (kappa,0.10).
Conclusions: Serological tests were inaccurate for diagnosing asymptomatic infections compared to molecular methods;
this could lead to misclassification bias in population studies. Therefore, studies which have used serological assays to
estimate prevalence, to evaluate intervention programs or to identify risk factors for Leishmania infection, may have had
their results compromised.
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Introduction
The global number of new human cases of visceral leishmaniasis
(VL) or kala-azar is estimated to be about 500,000 per year;
Bangladesh, Brazil, India, Nepal, Ethiopia and Sudan account for
approximately 90% of the estimated global disease prevalence [1].
In Brazil, VL is caused by Leishmania (Leishmania) infantum
(=L.chagasi), a zoonotic infection transmitted mainly by Lutzomyia
(Lutzomya) longipalpis, having as reservoirs wild and domestic canids.
Initially, it was characterized as an endemic infection from rural
areas, occurring primarily at Northeastern States of Brazil. During
the last decade, an increasing number of clinical VL is being
reported from Brazilian large cities, such as the metropolitan region
of Belo Horizonte, Minas Gerais State capital. VL incidencerates in
this State, located in the Southeast region of Brazil, were 2.6 and
2.1/100.000 population in 2005 and 2006, respectively [2].
Visceral leishmaniasis is a chronic and progressive systemic
disease characterized by fever, weight loss and hepatosplenomegaly;
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diagnosis and treatment are essential; however, due to the lack of
specificity of VL clinical symptoms, the infection should be
confirmed by parasite finding or antibody-detection tests. VL
induces a strong B cell activation resulting in hypergammaglobu-
linemia [3]. Antibody-detection tests, such as direct agglutination
test (DAT), immunofluorescence antibody test (IFAT) and enzyme-
linked immuno-fluorescent assay (ELISA) have shown high
diagnostic accuracy in confirming suspected cases of clinical VL.
Most soluble antigens used for ELISA assays are derived from
promastigotes of different species of Leishmania cultivated in vitro,
especially L.amazonensis, specie that can be easily grown under in
vitro conditions [3]. The rK39 recombinant protein that is
conserved within the L.donovani complex has also been used in
ELISA tests with high sensitivity and specificity [4].
L.infantum infection in humans does not always result in clinical
illness. A large proportion of asymptomatic VL has been reported
from areas of parasite transmission [5–9]. In endemic areas of
Brazil, asymptomatic infections are far more numerous than
clinical VL; however the relevance of asymptomatic infection in
parasite transmission and disease outcome is mostly unknown.
Based on serology, the prevalence of asymptomatic infection in
population studies ranged from 2.4 to 14% [6,10,11]. One of the
most important drawbacks in these studies is the difficulty of
diagnosing asymptomatic VL patients, probably due to the fact
that they present low levels of antibodies and minute amounts of
circulating parasites, compared to symptomatic patients [12,13].
This would explain the conflicting results from studies using
leshmanin skin test and serology in diagnosing asymptomatic VL
patients [10,14,15]. Molecular biology techniques, such as
polymerase chain reaction (PCR) alone or in combination with
hybridization have been used to confirm the diagnosis of VL in
suspect cases. These techniques present high sensitivity (ranged
from 75.0 to 98.0%) and specificity (ranged of 97 to 100%) to
identify the infection in individuals with low parasite burden, low
antibody reactivity and absence of symptoms [13,16–18].
The aim of the present investigation was to evaluate the
performance of ELISA assays, (using L.infantum and L.amazonensis
promatigotes crude antigens and rK39 recombinant protein),
compared to PCR and hybridization (reference tests) to diagnose
asymptomatic VL infection in participants from a cohort study
with a two-year follow-up period.
Material and Methods
Study design and population
The study was approved by the Ethical Review Board of the
Universidade Federal de Minas Gerais (No. 081/98). All partic-
ipants or their legal guardians were required to sign the Informed
Consent Form before data collection.
The participants (136) were selected from a population-based
cohort of individuals, being followed since 1999, living in an area
with active L.infantum transmission (urban area of General
Carneiro, Sabara ´ City, Metropolitan Region of Belo Horizonte,
capital of Minas Gerais State, Brazil). At baseline, 97 and 39
individuals, according to PCR/hybridization results, were classi-
fied as positive or negative for L.infantum infection, respectively; all
positive participants were asymptomatic [6]. They were re-
evaluated in 2001 (present investigation); during this period, none
of the infected participants had progressed to clinical disease.
Blood samples from 22 non-infected individuals and from 8
patients with clinical VL, all of them residents of the metropolitan
region of Belo Horizonte, were also assayed for comparison and
laboratory techniques quality control.
Clinical exams
The participants were clinically examined for signs and
symptoms of VL; anthropometric measures were also recorded.
Results were registered in a standardized protocol.
Sample collection
Blood samples were collected in vacuum tubes containing
EDTA. After centrifugation, plasma was aliquoted and kept at
220uC until use in ELISA tests. Peripheral blood mononuclear
cells (PBMC) were isolated in Ficoll-Paque gradient and also kept
at 220uC until be used for DNA extraction.
Antigens
Each plasma sample was tested against three different Leshmania-
antigen preparations: crude extract from L.infantum, crude extract
form L.amazonensis and rK39 recombinant antigen. For antigen
preparation, L.infantum (MHOM/BR/1972/BH46) or L.amazonen-
sis (MHOM/BR/1960/BH6) promastigotes were grown to
stationary phase in LIT (Liver Infusion Tryptose) medium. The
crude antigens were prepared as previously described [19]. The
rK39 antigen was prepared according to procedures described by
Burns et al. [20] and provided by Heska Corporation, USA.
ELISA-assay
Leshmania-reactive IgG1 antibody, the predominant IgG isotype
in VL infection [21] was tested by ELISA in the plasma samples.
The assays were performed using the methodology described
before [19]. Reactive antibody was detected with horseradish
peroxidase-conjugated anti-human IgG1, (Sigma), diluted 1:1000
in PBS. The absorbance was measured in a microplate reader
(Labsystems Multiskan RC) at 492 nm. The cut-off values were
established for each antigen tested, and calculated based on the
mean of absorbance value plus 2 standard deviations from 22
plasma samples of healthy control group. Therefore, reactive
samples had OD superior to 0.085 when tested against
L.amazonensis crude antigen, 0.032 against L.infantum crude antigen
and 0.039 against rK39.
Author Summary
Visceral leishmaniasis or kala-azar in Brazil, caused by a
parasite protozoon, is transmitted to humans by sandflies
and has wild and domestic dogs as reservoirs. The disease
can become chronic, characterized by fever, weight loss,
and enlargement of the liver and spleen. However, the
infection in humans can be asymptomatic, and the
importance of this phase is unknown. The low levels of
immune response and the small number of circulating
parasites in the blood are the main problems in identifying
the asymptomatic phase. In this study we evaluated the
performance of the serology tests compared with molec-
ular tests to identify asymptomatic infection in individuals
identified in an urban area of Brazil. Also included were
non-infected individuals (healthy controls) and patients
(diseased controls). Blood was collected and examined by
different serological methods and compared with molec-
ular techniques. The presence of the parasite was
confirmed by all molecular techniques and should be the
method used to identify true infection. The serology
methods showed low sensitivity in detecting the infection.
We concluded that the serologic methods are inaccurate in
identifying asymptomatic infection when compared to
molecular techniques and could underestimate the
infection in population studies.
Inaccuracy of ELISA to detect L. infantum
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The DNA was extracted from PBMC of each participant and
stored at 4uC [6]. Two PCR protocols were performed. In the first
protocol, a sample of DNA was amplified using a pair of generic
primers [59-(G/C)(G/C)(C/G) CC(A/C) CTA T(A/T) T TAC
ACC AAC CCC - 39 and 59-GGG GAG GGG CGT TCT GCG
AA – 39] described by Degrave et al. [22] that amplify a fragment
of 120 bp of the conserved region of Leishmania kDNA minicircle.
The PCR reaction was done as specified by Moreno et al. [6]. The
reaction products were visualized in 5% polyacrylamide gel
electrophoresis stained with silver and a 100-bp DNA ladder
(Gibco BRL) was used as marker. These amplified DNA were
denatured, applied on nylon membranes (Biodyne A, Gibco BRL)
using a bio-dot apparatus (Hybri-dot manifold-BRL) and hybrid-
ized using probes composed of cloned minicircles from L.infantum
radiolabeled with 32P - [a]dCTP, as previously described, to
confirm the infection by a Leishmania of the donovani complex
[22,23].
In the second protocol, to confirm L. infantum infection, a PCR
was performed in the same samples of DNA using a pair of
primers [59- ACG AGG TCA GCT CCA CTC C-39 and 59-CGT
AGA CAC AGG CGT TGC AG-39] that amplify a fragment of
100 bp and is specific to L.donovani complex. The PCR reaction
was done according to Piarroux et al. [24].
Appropriated positive controls, consisting of promastigote DNA,
and samples with no DNA as negative controls were used in all
performed reactions. To confirm DNA integrity, negative DNA
samples were also tested for the human ß-globin gene using [59-
CAA CTT CAT CCA CGT TCA CC- 39 and 59-ACA CAA
CTG TGT TCA CTA GC- 39] as primers. Procedures to avoid
carryover contamination from previously amplified DNA were
used routinely.
Anti-Trypanosoma cruzi antibodies
Due to cross-reactivity in serological tests, serum samples were
also assayed for Trypanossoma cruzi antibodies using indirect
hemagglutination (Chagas Kit -FUNED-SES/MG, Brazil) and
IFAT (Chagas Kit –BioManguinhos – FIOCRUZ, Brazil).
Reproducibility
Ten percent of blood samples and DNA samples were randomly
selected to be masked re-tested; each duplicate received a different
number from the original sample.
Statistical analysis
Tables of contingency, x
2 and Fisher exact test were used to
compare the diagnosis tests. Non parametric tests (Kruskal Wallis
and Dunn test) were used to compare the quantitative results. The
validity of the serological tests was estimated by the sensitivity,
specificity and likelihood ratios using the results of molecular
techniques (PCR/hybridization) as the reference standard. The
ROC curve was used to estimate the performance of each antigen
to identify the infection. The agreement between qualitative tests
was estimated by the kappa statistic [25].
Results
Participants mean and median age were 34.0620.6 and 32
years (IQR 14, 51), respectively; females comprised 54.4% of the
sample. The mean time of residence in the region was 18611.3
years.
All assays (molecular and serological tests) were negative for the
22 healthy controls and positive for the 8 patients with kala-azar.
PCR results for 136 participants showed 117 positive (Leishmania
primers; amplified product hybridized with radiolabed probe
specific for L.donovani complex) and 19 negative. Similar results
were obtained with the second PCR protocol (specific primers for
the L.donovani complex), showing 100% agreement. An illustrative
example of the PCR products obtained from the amplification of
DNA extracted from PBMC of negative-control, VL symptomatic
patients and some participants of the cohort study, using each
PCR procedure, can be seen in Figure 1.
It should be emphasized that (1) among the 117 PCR/
hybridization positive participants, 80 were positive at baseline
and 37 became positive during follow-up; (2) among the 19 PCR/
hybridization negative, 17 were positive at baseline and became
negative, and 2 remained negative during follow-up; (3) none
developed clinical VL during follow-up (see Table 1).
Regarding serological assays, higher median absorbance values
were observed comparing the 136 cohort participants with healthy
controls (Kruskall Wallis, p,0.001) using both L.amazonensis and
L.infantum crude antigens; this difference was not observed when
rK39 antigen was used. Moreover, median absorbance values for
Figure 1. PCR and hybridization products to identify L.
donovani complex in blood samples. A: PCR products obtained
with primers specific for the L. donovani complex (Piarroux, 1993);
molecular size markers (lane 1), positive control (lane 2-kDNA extracted
from cultured L.infantum), VL patient (lane 3), asymptomatic (lanes
4;7;9), health individuals (lane 5–6); negative control (lane 8- no DNA). B:
PCR products obtained with primers for genus Leishmania (Degrave et al
1994); molecular size markers (lane 1), VL patient (lane 2), positive
control (lane 3-kDNA extracted from cultured L. chagasi); healthy
individual (lane 4), asymptomatic (lanes 5–7, 9–10), negative control
(lanes 8 and 11- no DNA). C: Dot-blots obtained using specific probe for
the L. donovani complex, hybridized with PCR products.
doi:10.1371/journal.pntd.0000536.g001
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diseased controls (Kruskall Wallis, p,0.001, Figure 2). The same
results were observed when the comparisons were done without
the 19 PCR-negative cohort participants (data no shown).
In contrast with the molecular diagnosis, serological evaluation
of the 136 participants showed that only 67 (49.3%) plasma
samples were reactive for L.amazonensis antigen, 60 (44.1%) for
L.infantum and 36 (26.5%) for rK39. The evaluation of serological
results at the follow-up is shown in Table 1: (1) among the positive
participants in the first evaluation, 59.8% remained positive in
L.amazonensis-ELISA, 60.4% in L.infantum-ELISA and 38.5% in
rk39-ELISA; (2) among the negative participants in the first
evaluation, 33.3% became positive in L.amazonensis-ELISA, 33.7%
in L.infantum-ELISA and 21.6% in rk39-ELISA.
The agreement between the serological tests is shown in Table 2;
poor kappa (,0.10) was observed for all comparisons. No
significant differences regarding tests agreement were detected
when the cut-off value for each antigen was modified from two to
three standard deviations (data not shown).
The evaluation of tests reproducibility (duplicates) showed an
excellent agreement for ELISA-L.infantum (kappa 0.88, 95% CI
0.39–1.4), good for ELISA-L.amazonensis (kappa 0.69, 95% CI
0.24–1.13) and good for rK39 (kappa 0.77 95% CI 0.53–1.00).
Table 3 shows the comparison of serological and molecular
results. Sensitivity and specificity were estimated using the
molecular methods as reference. The crude antigens showed
higher sensitivity (49.6% and 41% for L.amazonensis and L.infantum
respectively) than rK39 (26.5%); rK39 was more specific (73.7%)
than L.amazonensis (52.6%) and L.infantum (36.8%). The likelihood
ratio for each antigen showed a lower power to determine the
occurrence of the infection. The combined sensitivity and
specificity [25] for serological assays were 80.4% and 14.3%,
respectively.
The serological tests ROC curves were uninformative. The
areas under the curve for each antigen were: Elisa-
L.infantum=0.36 (95% CI 0.22–0.50); Elisa-L.amazonensis=0.57
(95% CI 0.42–0.72); Elisa-rk39=0.53 (95% CI 0.39–0.68).
The simultaneous response to the antigens used can be seen on
Table 4. Among the 117 individuals who tested positive in the
molecular biology techniques, only 6 (5.1%) responded simulta-
neously to the three antigens, whereas 31 (16.5%) did not test
positive in any of them; 86 (73.5%) had at least one positive
serology. On the other hand, 15/19 (78.9%) molecular biology
negative participants tested positive for at least one of the three
antigens.
Six participants were identified as T.cruzi infected (IFAT and
Indirect Hemagglutination). They were also positive in molecular
techniques (L.donovani complex probe), suggesting co-infection.
The demographic and clinical characteristics of the infected and
reactive individuals to at least one serologic test (n=86) were
compared to those of non-reactive individuals (n=31). Among the
characteristics evaluated (gender, age, time in which the person
has been living in the study area, nutritional status, hemogram
results and clinical findings) only age was different among the
groups. The infected and seroreactive individuals were older
(median=42 years, IQR=18, 52) than the nonreactive infected
individuals (median=17 years, IQR=12, 29).
Discussion
In this study, a perfect agreement was observed comparing PCR
conducted with two different primers and confirmed with specific
probe for donovani complex, indicating a high accuracy in
identifying L.infantum infection. Therefore, molecular techniques
were used as reference tests in the evaluation of this infection
among cohort participants. During follow-up, no participants
developed symptomatic VL, although most of them had remained
positive in molecular assays.
On the other hand, the serologic methods showed to be
inadequate and inaccurate in identifying L.infantum asymptomatic
infection. The crude antigens and the recombinant antigen used
showed low validity, i.e. none was able to identify all infected
individuals. In addition, high disagreement was found when they
were compared, although good and excellent agreements were
observed when their reproducibility was tested.
Serological assays showed significant lower absorbancy levels in
diagnosing asymptomatic individuals compared to kala-azar
patients. These results indicate the occurrence of low levels of
antibodies in the blood of these individuals, which was already
suggested by different authors [12,13]. Regardless the fact that
most cohort participants have maintained their positivity (molec-
ular techniques) the serological tests showed low reactivity
reinforcing the results from the cohort baseline [6].
Table 1. Positive tests for Leishmania infantum infection among the 136 cohort participants at baseline and 24 months of follow-
up. General Carneiro, Minas Gerais.
Diagnostic Test Positive at Baseline evaluation Follow-up
Remained positive (%)
(1) Became positive (%)
(2) Total of positive (%)
PCR/hybridization 97/136 (71.3) 80/97 (82.5) 37/39 (94.8) 117/136 (86.0)
L. amazonensis-ELISA 82/136 (60.2) 49/82 (59.8) 18/54 (33.3) 67/136 (49.3)
L. infantum-ELISA 53/136 (40.0) 32/53 (60.4) 28/83 (33.7) 60/136 (44.1)
rK39-ELISA 39/136(28.7) 15 /39(38.5) 21/97 (21.6) 36/136 (26.5)
Negative at Baseline evaluation Remained negative (%)
(2) Became negative (%)
(1) Total of negative (%)
PCR/hybridization 39/136 (28.7) 2/39 (5.1) 17/97 (17.5) 19/136 (14.0)
L. amazonensis-ELISA 54/136 (39.8) 36/54 (66.7) 33/82 (40.2) 69/136 (50.7)
L. infantum-ELISA 83/136 (60.0) 55/83 (66.3) 21/53 (39.2) 76/136 (55.9)
rK39-ELISA 97/136 (71.3) 76/97 (78.4) 24/39 (61.5) 100/136 (73.5)
(1)among those positive at baseline.
(2)among those negative at baseline.
doi:10.1371/journal.pntd.0000536.t001
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have different accuracy in diagnosing L.infantum infection. Plasma
which detect homologous antigen may not detect heterologous
antigen or vice-versa. The rK39 recombinant antigen presented
the lowest sensitivity and the highest specificity in identifying
asymptomatic individuals, which was already recognized in
different studies [4,26].
Only 5.1% (6/117) of the infected individuals were simulta-
neously positive in all antigens. However, using all possible
combinations, it is possible to identify 73.5% (86/117) of the
infected individuals. Therefore, the use of more than one
serological diagnostic method increases the probability to
recognize asymptomatic individuals [8,27]. But it should be
considered that, due the low specificity of serological methods,
false-positive results could be included. In this study, the
percentage of false-positive in the serology was quite high
(78.9%=15/19).
It is known that tests performed in parallel increase the
sensitivity and decrease the specificity of the diagnosis. Our results
of combined sensitivity and specificity (80.4% and 14.3%,
respectively) confirmed the tests low accuracy in identifying
asymptomatic carriers.
Serological tests poor concordance may be explained by the low
level of antibody production, due to the small number of parasites
observed in asymptomatic carriers when compared to clinical
patients [12,13] and the performance of crude and recombinant
antigens in identifying the infection. Crude antigens derived from
promastigotes cultivated in vitro consist of a repertoire of somatic
antigens and several surface components that vary according to
parasite species used as antigens [3].
Total soluble antigens or recombinant antigens, traditionally
used in ELISA tests, are adequate to confirm the diagnosis in a
suspect VL case. In addition, it has been recognized that accuracy
is not a fixed test property; it can vary with the clinical settings and
with the spectrum of disease (spectrum bias). Therefore, in field
conditions and in individuals with low level of humoral immune
response, test performance can be affected [8,15,27]. Our
limitation in evaluating the accuracy of serological tests was the
small number of individuals not infected in the study population;
the measurements had wide confidence intervals.
Age was the only risk factor associated to the different antigens
reactivity: infected individuals positive in at least one antigen were
older (median=42 years) than those non-reactive (median=17
years). The meaning of this finding deserves further investigation.
Diagnostic tests results can be questioned due the possibility of
cross reactivity with other parasite infections in the studied
population. Low incidence rate of cutaneous leishmaniasis, caused
by Leishmania braziliensis, has been reported from Sabara City.
However, in our study, during the anamnesis and clinical
examination, cohort participants did not present any clinical
symptoms or report a history of cutaneous disease. Moreover,
molecular techniques used in our experimental protocol are
specific for L.donovani complex (L.infantum in the New World)
diagnosis, therefore excluding L.braziliensis infection.
As pointed out in our results, six participants were co-infected
with L.infantum and T.cruzi. Although cross-reactivity among
Leishmania and T.cruzi antigens has been reported, it is important
to note that molecular techniques used herein are specific for L.
donovani complex; in addition the studied population showed low
reactivity in ELISA tests. The proportion of T.cruzi-L.infantum co-
infected participants did not interfere in the analysis of
asymptomatic infection.
This study has the advantage of using molecular techniques to
correctly identify infected individuals; most studies on asymptom-
atic used only one serological test or skin tests. Positive molecular
methods suggest the presence of living parasites. Recent studies by
microscopy and real-time PCR demonstrated that Leishmania DNA
detected by PCR is derived from intact parasites; DNA is rapidly
degraded following amastigote death. Positive result is correlated
Figure 2. Comparison of absorbances between cohort’s
participants, positive and negative controls, using three
different antigens. A: L. amazonensis. B: L.infantum. C, rK39.
Healthy=22 negative controls; Cohort=136 inhabitant of endemic
area; VL=8 positive controls (patients with visceral leishmaniasis).
Differences statistically significant were sign (p,0.05, p,0.001, Kruskall
Wallis and Dunn’s test).
doi:10.1371/journal.pntd.0000536.g002
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obtained after parasitological cure [28].
Notwithstanding the high agreement observed between molec-
ular techniques and the persistence of its positivity in most cohort
participants, important questions remain to be answered: (1) what
was the meaning of a positive PCR in individuals that did not
progressed to symptomatic VL during the follow-up? (2) why some
participants, living in a transmission area, changed their status
from positive to negative? To answer these questions, a longer
follow-up period may be necessary in order to understand the role
of a persistent positive PCR in the disease process. It should also be
considered that participants live in transmission areas, being
exposed to re-infection.
Why it is important to use an accurate test in identifying an
asymptomatic infection? Firstly, to obtain reliable estimate of
infection occurrence in endemic and in recent transmission areas.
This information will be useful to prioritize and to evaluate control
measures. Currently, there is no evidence that infected or
asymptomatic individuals can act as L.infantum host in urban
areas; the probability of a phlebotomine being infected when
feeding in an asymptomatic individual seems to be very low [29].
However, it is important to consider the number of asymptomatic
individuals in urban areas and the environmental conditions which
may favor man-vector transmission [8,9,27,30]. Secondly, infected
individuals may become immunocompromised, altering their
course of infection and parasitaemia [31].
In conclusion, molecular techniques are better suited for
evaluation studies, as they can minimize misclassification bias in
population based investigations. Serological tests can not be
reliably used as a tool to identify asymptomatic individuals,
Table 2. Agreement between crude (L.amazonensis, L.infantum) and recombinant antigens (rK39) in sera from cohort participants,
General Carneiro, Minas Gerais.
Comparisons Agreement Total Agreement (%) Kappa (95% CI)
Positive in both (%) Negative in both (%)
L amazonensis vs. L. infantum 33 (24.3) 42 (30.9) 75 (55.1) 0.10 (20.07–0.269)
L amazonensis vs. rK39 21 (15.4) 54 (39.7) 75 (55.1) 0.10 (20.05–0.246)
L. infantum vs. rK39 15 (11.0) 55 (40.4) 70 (51.5) 20.03 (20.183–0.128)
Denominators of the estimated proportions were 136 participants.
doi:10.1371/journal.pntd.0000536.t002
Table 3. Validity of serological tests in comparison with molecular test to identify L. infantum infection of 136 participants of a
cohort study, General Carneiro, Minas Gerais.
Serological Test TP FP FN TN
Sensitivity (%)
(95% CI)
Specificity (%)
(95% CI)
LR+
(95% CI)
LR2
(95% CI) Kappa
L. amazonensis 58 9 59 10 49.6 (40.3–58.9) 52.6 (29.5–74.8) 1.1 (0.8–1.4) 1.0 (0.8–1.2) 0.01
L. infantum 48 12 69 7 41.0 (32.1–50.5) 36.8 (17.2–61.4) 0.7 (0.5–0.8) 1.6 (1.0–2.7) 20.10
rK39 31 5 86 14 26.5 (19.0–35.6) 73.7 (48.6–89.9) 1.0 (0.6–1.8) 1.0 (0.9–1.7) 20.00
Molecular techniques were used as reference test. Criteria: Positive results=positive in PCR with generic primer and specific primer for L.donovani complex and positive
in hybridization. Negative results=negative in all molecular techniques.
TP=True Positive; FP=False positive; FN=False Negative; TN=True Negative; LR+=Likelihood test positive; LR2=Likelihood test negative.
doi:10.1371/journal.pntd.0000536.t003
Table 4. Comparison between serological results according to the reactivity to different antigens with molecular techniques
results, General Carneiro, Minas Gerais.
Serological Results Molecular Techniques Total (%)
Positive
(4) (n=117) Negative
(5) (n=19)
Positive test with three antigens
(1) 6 1 7(5.1)
Positive tests with two antigens
(2) 39 9 48(35.3)
Positive test with one antigen
(3) 41 5 46(33.8)
Negative tests with three antigens 31 4 35(25.7)
Total 117 19 136
(1)L. amazonensis, L. infantum and rK39.
(2)L. amazonensis and L. infantum, L. amazonensis and rK39, L. infantum and rK39.
(3)L. amazonensis or L. infantum or rK39.
(4)Positive=Infected (positive PCR with two primers and confirmed by hybridization).
(5)Negative=No infected (negative in molecular techniques).
doi:10.1371/journal.pntd.0000536.t004
Inaccuracy of ELISA to detect L. infantum
www.plosntds.org 6 October 2009 | Volume 3 | Issue 10 | e536especially when only one antigen is used. In the impossibility of
carrying out molecular tests, one should weigh the consequence of
using serological techniques to identify asymptomatic carriers in
population studies: probably, around 20 to 30% of infected
individuals will be missed. On the other hand, to carry out studies
using PCR with a large number of samples under field conditions
is difficult and expensive; the feasibility of this approach needs to
be better appraised. Further studies to develop and to validate new
diagnostic methods for asymptomatic L.infantum infection are
urgently needed; these new tools are essential in population based
investigations: they should allow the valid and reliable identifica-
tion of all infected individuals.
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